ObjectiveTo determine the rate and risk factors for osteoradionecrosis (ORN) in osseous free flaps after postoperative radiation therapy (PORT). To describe the treatment of free flap ORN.MethodsSeventy‐four patients undergoing osseous free flap reconstruction were analyzed. Thirty‐eight completed PORT. Patients were followed for ≥6 months.ResultsThe rate of ORN was 34% overall; 0% with 50 to 59.9 Gy; 8% with 60 Gy; 40% with 66 Gy; 56% with 70 to 74.4 Gy. Mean time to ORN was 13.1 months. 0/28 patients without PORT developed free flap osteonecrosis. Multivariate analysis found the only factor predicting ORN: PORT >60 Gy, which increased the risk 21‐fold. Treatment included PENTACLO, hyperbaric oxygen, and surgical debridement with 75% within 2 years.ConclusionPORT >60 Gy is significantly associated with free flap ORN. As the dose of adjuvant RT increases beyond 60 Gy, the risk of ORN in free flaps rises. Consideration should be given to lower PORT doses or delaying free flap reconstruction when feasible.
ObjectiveUtilization of free tissue transfers in head and neck reconstruction has greatly increased due to their dependability and reliability. Anterolateral thigh (ALT) and rectus abdominus (RA) free flaps may provide too much soft tissue bulk, especially in patients with a large body habitus. A radial forearm free flap (RFFF) may be modified with a “beaver tail” (BT), which provides a flap whose bulk may be tailored to a defect. The purpose of this paper is to describe the technique, how it can be used for a variety of defects and the outcomes of these reconstructions.MethodsA retrospective review of prospectively collected data was performed at single tertiary care center between 2012 and 2022. BT‐RFFF was designed by leaving a fibroadipose tail vascularized to branches of the radial artery or separated from the vascular pedicle and left attached to the proximal portion of the skin paddle. Functional outcomes, tracheostomy dependence, and gastrostomy tube (G‐tube) dependence as well as complications were determined.ResultsFifty‐eight consecutive patients undergoing BTRFFF were included. Defects reconstructed included: oral tongue and/or floor of mouth 32 (55%), oropharynx 10 (17%), parotid 6 (10%), orbit 6 (10%), lateral temporal bone 3 (5%), and mentum 1 (2%). Indications for BTRFF were: need for bulk when the ALT and RA were too thick (53%) and need for a separate subcutaneous flap for contouring or deep defect lining (47%). Complications directly related to beavertail included a widened forearm scar (100%), wrist contracture (2%) partial flap loss (2%), and flap loss requiring a revision flap (3%). Ninety‐three percent of patients with oral/oropharyngeal defects and 12‐month follow‐up tolerated oral intake without aspiration and 76% were tube‐independent. Ninety‐three percent were tracheostomy‐free at last follow‐up.ConclusionThe BTRFF is a useful tool for reconstructing complex 3D defects requiring bulk where an ALT or rectus would otherwise provide too much bulk.
Soft tissue free flaps are used for a variety of head and neck reconstructions. The anterolateral thigh (ALT) flap has been a versatile tool in head and neck reconstruction since the mainstream use of microvascular anastomosis for free tissue transfer. The ALT flap has a known history of variable vascular anatomy. Most of this variability lies within perforator anatomy and vascular aberrations distal to the lateral circumflex femoral artery (LCF). Few vascular aberrancies have been described proximal to the LCF. Here we present a case of report of an ALT whose arterial vascular pedicle was a branch directly off the femoral artery. The case highlights an unusual anatomical variant of the ALT flap, and the importance of a thorough and meticulous dissection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.